Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Atul Limited logo

Atul Limited

ATUL·Chemicals
  • Nifty 500

Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses.

99Announcements
07-09-2026Last filed
17Last 90 days

What Atul files

  • Others50
  • Important24
  • Updates13
  • Board Meeting6
  • Dividend/Bonus2
  • Investor Meet1
Showing Updates announcements (13)Clear filter
05-08-2026 · 02:04 pm

Atul Limited has informed the Exchange about General Updates

Read the full announcement→
PDF
25-07-2026 · 03:02 pm

Atul Limited's board approved Q1 unaudited standalone and consolidated financial results. These results for the first quarter are now public via newspaper publication. #AtulLtd #Earnings

Read the full announcement→
PDF
07-07-2026 · 04:50 pm

Company proposed a ₹30/share dividend for FY26, pending shareholder approval at the upcoming 49th AGM. Integrated annual report is now available online. Physical shareholders should update KYC for dividend receipt.

Read the full announcement→
PDF
02-06-2026 · 03:57 pm

Atul is transferring shares to a government fund due to 7+ years of unclaimed dividends. Shareholders should contact the RTA to claim unpaid dividends and prevent transfer. Reclaim from the fund is possible later.

Read the full announcement→
PDF
24-04-2026 · 02:32 pm

Atul Ltd. reported strong FY26 consolidated revenue of ₹6,273.54 Cr & profit of ₹677.90 Cr (EPS ₹230.25). Board proposed ₹30/share dividend. MD Mr. Samveg Lalbhai reappointed for 5 years. Q4 profit included a ₹25.41 Cr employee benefit provision reversal.

Read the full announcement→
PDF